Société Sarepta Therapeutics, Inc. Sao Paulo
Actions
S1RP34
BRS1RPBDR005
Recherche biotechnologique et médicale
Marché Fermé -
Autres places de cotation
|
Varia. 5j. | Varia. 1 janv. | ||
31,89 BRL | -2,06% | -3,97% | +38,89% |
17/05 | SAREPTA THERAPEUTICS, INC. : Mizuho Securities optimiste sur le dossier | ZM |
14/05 | SAREPTA THERAPEUTICS, INC. : Oppenheimer relève sa recommandation à acheter | ZM |
Métier
Nombre d'employés: 1 314
Ventes par activité
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
RNA-targeted Therapeutics, Gene Therapy and Other Genetic Therapeutic Modalities
100,0
%
| 933 | 100,0 % | 1 243 | 100,0 % | +33,26% |
Ventes par région
USD en Millions | 2022 | Poids | 2023 | Poids | Delta |
---|---|---|---|---|---|
United States
100,0
%
| 933 | 100,0 % | 1 243 | 100,0 % | +33,26% |
Dirigeants
Dirigeants | Titre | Age | Depuis |
---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 61 | 26/06/17 |
Ian Estepan
DFI | Director of Finance/CFO | 48 | 01/01/15 |
Bilal Arif
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | 48 | 01/06/18 | |
Will Tilton
HRO | Human Resources Officer | - | - |
Alison Nasisi
HRO | Human Resources Officer | - | - |
Dallan Murray
PRN | Corporate Officer/Principal | - | 01/01/13 |
Diane Berry
PRN | Corporate Officer/Principal | - | 01/12/11 |
Ryan Brown
LAW | General Counsel | 46 | 01/01/18 |
Joseph Bratica
AUD | Comptroller/Controller/Auditor | 60 | 01/03/17 |
Administrateurs
Administrateurs | Titre | Age | Depuis |
---|---|---|---|
Douglas Ingram
CEO | Chief Executive Officer | 61 | 26/06/17 |
M. Wilsey
CHM | Chairman | 71 | 31/03/09 |
Richard Barry
BRD | Director/Board Member | 65 | 02/06/15 |
Director/Board Member | 86 | 01/06/10 | |
Stephen Mayo
BRD | Director/Board Member | 62 | 16/11/21 |
Claude Nicaise
BRD | Director/Board Member | 71 | 02/06/15 |
Michael Chambers
BRD | Director/Board Member | - | 02/06/22 |
Kathryn Boor
BRD | Director/Board Member | 65 | 02/06/22 |
Classe d'actions
Vote | Nombre | Flottant | Autocontrôle | Flottant Total | |
---|---|---|---|---|---|
Action A | 1 | 94 523 766 | 89 825 408 ( 95,03 %) | 0 | 95,03 % |
Coordonnées société
Sarepta Therapeutics, Inc.
215 First Street Suite 415
02142, Cambridge
+617 274 4000
http://www.sareptatherapeutics.comSecteur
Révisions de BNA
Varia. 1 janv. | Capi. | |
---|---|---|
+12,30% | 118 Md | |
+12,15% | 106 Md | |
-8,14% | 23,4 Md | |
-1,69% | 21,78 Md | |
-10,60% | 18,09 Md | |
-41,25% | 16,72 Md | |
-15,33% | 15,97 Md | |
+5,80% | 14,03 Md | |
-2,52% | 7,53 Md |
- Bourse
- Actions
- Action SRPT
- Action S1RP34
- Société Sarepta Therapeutics, Inc.